Goldman Sachs’s ICU Medical ICUI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $41.7M | Buy |
322,691
+38,140
| +13% | +$5.48M | ﹤0.01% | 1720 |
|
|
2025
Q4 | $40.6M | Buy |
284,551
+5,837
| +2% | +$782K | 0.01% | 1683 |
|
|
2025
Q3 | $33.4M | Buy |
278,714
+78,094
| +39% | +$9.89M | ﹤0.01% | 1771 |
|
|
2025
Q2 | $26.5M | Sell |
200,620
-140
| -0.1% | -$19K | ﹤0.01% | 1873 |
|
|
2025
Q1 | $27.9M | Sell |
200,760
-48,522
| -19% | -$7.53M | ﹤0.01% | 1711 |
|
|
2024
Q4 | $38.7M | Buy |
249,282
+78,537
| +46% | +$13.3M | 0.01% | 1520 |
|
|
2024
Q3 | $31.1M | Buy |
170,745
+88,300
| +107% | +$13.1M | 0.01% | 1661 |
|
|
2024
Q2 | $9.79M | Buy |
82,445
+41,701
| +102% | +$4.39M | ﹤0.01% | 2530 |
|
|
2024
Q1 | $4.37M | Buy |
40,744
+13,026
| +47% | +$1.3M | ﹤0.01% | 3219 |
|
|
2023
Q4 | $2.76M | Buy |
27,718
+9,113
| +49% | +$891K | ﹤0.01% | 3668 |
|
|
2023
Q3 | $2.21M | Sell |
18,605
-7,541
| -29% | -$1.13M | ﹤0.01% | 3687 |
|
|
2023
Q2 | $4.66M | Buy |
26,146
+4,459
| +21% | +$818K | ﹤0.01% | 3164 |
|
|
2023
Q1 | $3.58M | Sell |
21,687
-9,377
| -30% | -$1.61M | ﹤0.01% | 3371 |
|
|
2022
Q4 | $4.89M | Buy |
31,064
+7,598
| +32% | +$1.16M | ﹤0.01% | 3188 |
|
|
2022
Q3 | $3.53M | Sell |
23,466
-3,791
| -14% | -$631K | ﹤0.01% | 3460 |
|
|
2022
Q2 | $4.48M | Sell |
27,257
-6,326
| -19% | -$1.22M | ﹤0.01% | 3236 |
|
|
2022
Q1 | $7.48M | Buy |
33,583
+3,323
| +11% | +$744K | ﹤0.01% | 2974 |
|
|
2021
Q4 | $7.18M | Sell |
30,260
-3,788
| -11% | -$885K | ﹤0.01% | 3073 |
|
|
2021
Q3 | $7.95M | Buy |
34,048
+5,993
| +21% | +$1.26M | ﹤0.01% | 2941 |
|
|
2021
Q2 | $5.77M | Sell |
28,055
-1,761
| -6% | -$362K | ﹤0.01% | 3202 |
|
|
2021
Q1 | $6.13M | Buy |
29,816
+2,532
| +9% | +$535K | ﹤0.01% | 2957 |
|
|
2020
Q4 | $5.85M | Sell |
27,284
-21,824
| -44% | -$4.23M | ﹤0.01% | 2898 |
|
|
2020
Q3 | $8.98M | Buy |
49,108
+330
| +0.7% | +$62.1K | ﹤0.01% | 2422 |
|
|
2020
Q2 | $8.99M | Sell |
48,778
-6,208
| -11% | -$1.23M | ﹤0.01% | 2358 |
|
|
2020
Q1 | $11.1M | Buy |
54,986
+1,516
| +3% | +$292K | ﹤0.01% | 2014 |
|
|
2019
Q4 | $10M | Sell |
53,470
-11,847
| -18% | -$2.04M | ﹤0.01% | 2431 |
|
|
2019
Q3 | $10.4M | Sell |
65,317
-16,208
| -20% | -$3.23M | ﹤0.01% | 2296 |
|
|
2019
Q2 | $20.5M | Sell |
81,525
-3,702
| -4% | -$858K | 0.01% | 1836 |
|
|
2019
Q1 | $20.4M | Buy |
85,227
+6,758
| +9% | +$1.62M | 0.01% | 1845 |
|
|
2018
Q4 | $18M | Sell |
78,469
-35,232
| -31% | -$8.68M | 0.01% | 1886 |
|
|
2018
Q3 | $32.1M | Sell |
113,701
-96,772
| -46% | -$28.3M | 0.01% | 1553 |
|
|
2018
Q2 | $61.8M | Sell |
210,473
-63
| -0% | -$17.2K | 0.02% | 1053 |
|
|
2018
Q1 | $53.1M | Sell |
210,536
-156,652
| -43% | -$36.8M | 0.01% | 1151 |
|
|
2017
Q4 | $79.3M | Sell |
367,188
-15,737
| -4% | -$3.18M | 0.02% | 948 |
|
|
2017
Q3 | $71.2M | Sell |
382,925
-5,548
| -1% | -$967K | 0.02% | 1030 |
|
|
2017
Q2 | $67M | Buy |
388,473
+14,270
| +4% | +$2.29M | 0.02% | 1052 |
|
|
2017
Q1 | $57.1M | Buy |
374,203
+54,756
| +17% | +$8M | 0.02% | 1144 |
|
|
2016
Q4 | $47.1M | Buy |
319,447
+222,202
| +228% | +$32.2M | 0.01% | 1315 |
|
|
2016
Q3 | $12.3M | Buy |
97,245
+47,683
| +96% | +$5.75M | ﹤0.01% | 2285 |
|
|
2016
Q2 | $5.59M | Sell |
49,562
-6,228
| -11% | -$646K | ﹤0.01% | 2769 |
|
|
2016
Q1 | $5.81M | Buy |
55,790
+13,716
| +33% | +$1.31M | ﹤0.01% | 2614 |
|
|
2015
Q4 | $4.75M | Sell |
42,074
-32,664
| -44% | -$3.61M | ﹤0.01% | 2872 |
|
|
2015
Q3 | $8.18M | Sell |
74,738
-9,794
| -12% | -$1.05M | ﹤0.01% | 2412 |
|
|
2015
Q2 | $8.09M | Buy |
84,532
+13,091
| +18% | +$1.22M | ﹤0.01% | 2519 |
|
|
2015
Q1 | $6.65M | Sell |
71,441
-11,730
| -14% | -$1.03M | ﹤0.01% | 2632 |
|
|
2014
Q4 | $6.81M | Buy |
83,171
+40,078
| +93% | +$3.07M | ﹤0.01% | 2691 |
|
|
2014
Q3 | $2.77M | Buy |
43,093
+8,152
| +23% | +$499K | ﹤0.01% | 3608 |
|
|
2014
Q2 | $2.12M | Buy |
34,941
+26,928
| +336% | +$1.59M | ﹤0.01% | 3933 |
|
|
2014
Q1 | $480K | Sell |
8,013
-105,165
| -93% | -$6.48M | ﹤0.01% | 5316 |
|
|
2013
Q4 | $7.21M | Buy |
113,178
+42,645
| +60% | +$2.74M | ﹤0.01% | 2677 |
|
|
2013
Q3 | $4.79M | Buy |
70,533
+50,151
| +246% | +$3.58M | ﹤0.01% | 2971 |
|
|
2013
Q2 | $1.47M | Buy |
+20,382
| New | +$1.35M | ﹤0.01% | 4031 |
|
Other funds holding ICUI
VPM
VCM
RRAM
Goldman Sachs's ICUI Position: Q1 2026 in Review
Goldman Sachs increased its ICU Medical (ICUI) stake by 13% in Q1 2026, buying an estimated $5.48M and bringing the position to 322,691 shares worth $41.7M. The position accounts for ﹤0.01% of the portfolio, ranked #1720.
Goldman Sachs first reported a position in ICUI in Q2 2013 and has held it in 52 quarters since. The position peaked at $79.3M in Q4 2017. 275 funds tracked by Wall St. Rank hold ICUI as of Q1 2026.
- Goldman Sachs held 322,691 shares of ICU Medical worth $41.7M as of Q1 2026.
- Goldman Sachs bought 38,140 ICU Medical shares in Q1 2026, an estimated $5.48M.
- ICU Medical made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #1720 holding.
- Goldman Sachs first reported a position in ICU Medical in Q2 2013 and has held it in 52 quarters since.
- Goldman Sachs's ICU Medical position peaked at $79.3M in Q4 2017.
- 275 funds tracked by Wall St. Rank held ICU Medical as of Q1 2026.
Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.